Paul Heltzer
Obstetrics & Gynecology · Staten Island, NYNPI 1104809235
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $496 and has fallen 79.7% since, to $101 in 2024.
Across 124 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$463
- AbbVie$232
- Mayne Pharma Commercial LLC$180
- Therapeuticsmd, Inc.$180
- Organon$159
- Lupin Inc.$157
- plus $754 from 14 others
What the payments were for
- Food & beverage$2,10699%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 26 | $463 |
| AbbVie | 12 | $232 |
| Mayne Pharma Commercial LLC | 11 | $180 |
| Therapeuticsmd, Inc. | 10 | $180 |
| Organon | 10 | $159 |
| Lupin Inc. | 10 | $157 |
| Evofem Biosciences, Inc. | 9 | $138 |
| Scynexis, Inc. | 6 | $119 |
| Agile Therapeutics, Inc. | 5 | $72 |
| Merck | 4 | $64 |
| Avion Pharmaceuticals | 4 | $61 |
| Pfizer | 3 | $51 |
| Shield Therapeutics Inc | 3 | $51 |
| Mylan Pharmaceuticals Inc. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $46 |
| Myovant Sciences Inc. | 2 | $33 |
| Duchesnay USA Incorporated | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Coopersurgical, Inc. | 1 | $16 |
| Meditrina | 1 | $13 |
How this compares
$2,124 in reported general payments places this provider in the 80th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $614 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Staten Island
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.